Up listing brings the full BOD into play and changes Leo's level of accountability. This can potentially compel a CEO to delay up listing. Sometimes it may be in the best interest of the shareholders for the CEO to flexible and nimble.
My ire is this. If Leo continues to dither about up listing then the least he could have done was stayed on the OTC rather than put us in the pinkie swamp.
We're now living among the pink rats and complaining of fleas.
Market Data 
Markets 
AI
